LEADER 03568nam 2200505 450 001 9910424639003321 005 20221130183329.0 010 $a981-15-7590-8 024 7 $a10.1007/978-981-15-7590-7 035 $a(CKB)4100000011515526 035 $a(DE-He213)978-981-15-7590-7 035 $a(MiAaPQ)EBC6381074 035 $a(PPN)258064404 035 $a(EXLCZ)994100000011515526 100 $a20210326d2020 uy 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCompetitive strategies in life sciences /$fBasanta Kumara Behera, Ram Prasad, Shyambhavee Behera 205 $a1st ed. 2020. 210 1$aSingapore :$cSpringer,$d[2020] 210 4$dİ2020 215 $a1 online resource (XV, 189 p. 84 illus., 56 illus. in color.) 225 1 $aNew Paradigms of Living Systems ;$vVolume 1 311 $a981-15-7589-4 327 $aChapter 1. Strategies in Life sciences -- Chapter 2. Management and Manufacturing process of biologics -- Chapter 3. Downstream processes -- Chapter 4. Bioprinting -- Chapter 5. Biopharmaceuticals: New Frontier. 330 $aTailoring of biomolecules using protein engineering technology, and host cells culture techniques are among the most sophisticated and elegant achievements of modern applied life sciences in which the basic fundamentals biotechnology are applicable for the development and manufacturing of biologics and other related bio-molecules for a hurdle free life with good health. A majority of biologics derived from genetically modified host cells in the current market are bio-formulation such as antibodies, nucleic acid products and vaccines. Such bio-formulations are developed mainly in two steps i.e. upstream process and downstream process. The first volume of this series begins with the latest information on how the classical stepwise host cells culture (mammals, animals, plants, and bacteria) methodology has been changed to fully continuous or partially continuous host cells culture process in order to economise the biopharmaceutical products manufacturing process. In addition this volume narrates a brief history on conceptual development of new thoughts in designing biotechnology industries for commercial production of variety of therapeutic proteins with structural modification on the basis of clinical requirements. The readers will feel exited by going through the latest discovery and development in applied life sciences for designing innovative biomolecules for health care with utmost safe. The most interesting part of this volume is newly developed concept on bioprinting. It explains how to design and fabricate animate objects by fusing or depositing material of interest in the form of powders, solid dusts, metal, liquid or even living cells or tissues by layers to produce 3D objectives. The first volume ends with the latest information on the current trend in biologics market, market dynamic, drives, and opportunities with challenges. 410 0$aNew paradigms of living systems ;$vVolume 1. 606 $aBiomolecules 606 $aMolecular biology 606 $aNucleic acids 615 0$aBiomolecules. 615 0$aMolecular biology. 615 0$aNucleic acids. 676 $a574.19283 700 $aBehera$b Basanta Kumara$0947396 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910424639003321 996 $aCompetitive strategies in life sciences$92513672 997 $aUNINA